HK1250029A1 - 具有雙環結構的多巴胺d3受體拮抗劑 - Google Patents
具有雙環結構的多巴胺d3受體拮抗劑Info
- Publication number
- HK1250029A1 HK1250029A1 HK18109519.3A HK18109519A HK1250029A1 HK 1250029 A1 HK1250029 A1 HK 1250029A1 HK 18109519 A HK18109519 A HK 18109519A HK 1250029 A1 HK1250029 A1 HK 1250029A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- dopamine
- receptor antagonists
- bicyclo
- moiety
- bicyclo moiety
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Addiction (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1513871.2A GB201513871D0 (en) | 2015-08-05 | 2015-08-05 | Bicyclo dopamine D3 receptor antagonists |
| GBGB1518125.8A GB201518125D0 (en) | 2015-10-13 | 2015-10-13 | Dopamine D3 receptor antagonist having a bicyclo moiety |
| PCT/IB2016/054708 WO2017021920A1 (en) | 2015-08-05 | 2016-08-04 | Dopamine d3 receptor antagonists having a bicyclo moiety |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1250029A1 true HK1250029A1 (zh) | 2018-11-23 |
Family
ID=56801657
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK18109519.3A HK1250029A1 (zh) | 2015-08-05 | 2018-07-23 | 具有雙環結構的多巴胺d3受體拮抗劑 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US10273244B2 (zh) |
| EP (1) | EP3331886B1 (zh) |
| AU (1) | AU2016303558B2 (zh) |
| CA (1) | CA2992820C (zh) |
| DK (1) | DK3331886T3 (zh) |
| ES (1) | ES2821896T3 (zh) |
| HK (1) | HK1250029A1 (zh) |
| IL (1) | IL256914B (zh) |
| NZ (1) | NZ739139A (zh) |
| WO (1) | WO2017021920A1 (zh) |
| ZA (1) | ZA201800483B (zh) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3331886T3 (da) | 2015-08-05 | 2020-08-24 | Indivior Uk Ltd | Dopamin-d3-receptorantagonister med en bicyclo-del |
| EP3495363B1 (en) | 2016-07-28 | 2023-08-23 | Shionogi & Co., Ltd | Nitrogen-containing condensed ring compounds having dopamine d3 receptor antagonistic effect |
| WO2019084075A1 (en) * | 2017-10-24 | 2019-05-02 | The Trustees Of The University Of Pennsylvania | DOPAMINE RECEPTOR SELECTIVE ANTAGONISTS AND METHODS OF USING THE SAME |
| MX2020007849A (es) | 2018-01-26 | 2020-09-25 | Shionogi & Co | Compuesto ciclico condensado que tiene efecto antagonista del receptor de dopamina d3. |
| WO2019146740A1 (ja) | 2018-01-26 | 2019-08-01 | 塩野義製薬株式会社 | ドーパミンｄ３受容体拮抗作用を有する環式化合物 |
| EP3758695A4 (en) | 2018-02-28 | 2021-10-06 | The Trustees Of The University Of Pennsylvania | POLY (AD-RIBOSE) DEPENDENT CYTOTOXIC AGENTS LOW AFFINITY POLYMERASE-1 |
| EP3608326A1 (en) | 2018-08-10 | 2020-02-12 | Irbm S.P.A. | Tricyclic inhibitors of hepatitis b virus |
| CA3123215C (en) | 2018-12-19 | 2024-04-02 | Disarm Therapeutics, Inc. | Inhibitors of sarm1 in combination with neuroprotective agents |
| EP3825318A1 (en) | 2019-11-25 | 2021-05-26 | Promidis S.r.l. | Oxalamido-substituted tricyclic inhibitors of hepatitis b virus |
| EP3741762A1 (en) | 2019-05-23 | 2020-11-25 | Irbm S.P.A. | Oxalamido-substituted tricyclic inhibitors of hepatitis b virus |
| UY38705A (es) | 2019-05-23 | 2020-12-31 | Irbm S P A | Inhibidores tricíclicos sustituidos con oxalamido del virus de hepatitis b |
| CN110684028B (zh) * | 2019-10-28 | 2021-10-26 | 上海阿拉丁生化科技股份有限公司 | 一种2，6-二氮杂双环[3，3，0]辛烷类化合物的制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4341403A1 (de) * | 1993-12-04 | 1995-06-08 | Basf Ag | N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung |
| US5541217A (en) | 1995-05-17 | 1996-07-30 | Ortho Pharmaceutical Corporation | 4-arylcyclopenta[c]pyrrole analgesics |
| DK1745040T3 (da) | 2004-02-23 | 2010-04-12 | Glaxo Group Ltd | Som modulatorer af dopamin-D3-receptorer anvendelige azabicyclo(3.1.0)hexanederivater |
| GB0507680D0 (en) * | 2005-04-15 | 2005-05-25 | Glaxo Group Ltd | Compounds |
| WO2015048507A1 (en) * | 2013-09-26 | 2015-04-02 | Mnemosyne Pharmaceuticals, Inc. | Selective octahydro-cyclopenta[c] pyrrole negative modulators of nr2b |
| CN106659715A (zh) * | 2013-12-20 | 2017-05-10 | 药物发现研究所 | 取代的氨基三唑及其使用方法 |
| DK3331886T3 (da) | 2015-08-05 | 2020-08-24 | Indivior Uk Ltd | Dopamin-d3-receptorantagonister med en bicyclo-del |
-
2016
- 2016-08-04 DK DK16757355.9T patent/DK3331886T3/da active
- 2016-08-04 NZ NZ739139A patent/NZ739139A/en unknown
- 2016-08-04 CA CA2992820A patent/CA2992820C/en active Active
- 2016-08-04 US US15/750,128 patent/US10273244B2/en active Active
- 2016-08-04 ES ES16757355T patent/ES2821896T3/es active Active
- 2016-08-04 WO PCT/IB2016/054708 patent/WO2017021920A1/en active Application Filing
- 2016-08-04 AU AU2016303558A patent/AU2016303558B2/en active Active
- 2016-08-04 EP EP16757355.9A patent/EP3331886B1/en active Active
-
2018
- 2018-01-14 IL IL256914A patent/IL256914B/en active IP Right Grant
- 2018-01-23 ZA ZA2018/00483A patent/ZA201800483B/en unknown
- 2018-07-23 HK HK18109519.3A patent/HK1250029A1/zh unknown
-
2019
- 2019-03-04 US US16/292,110 patent/US10584135B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2016303558A1 (en) | 2018-02-08 |
| ES2821896T3 (es) | 2021-04-28 |
| DK3331886T3 (da) | 2020-08-24 |
| NZ739139A (en) | 2023-01-27 |
| US20180222918A1 (en) | 2018-08-09 |
| ZA201800483B (en) | 2019-07-31 |
| EP3331886B1 (en) | 2020-07-15 |
| IL256914A (en) | 2018-03-29 |
| IL256914B (en) | 2021-03-25 |
| CA2992820A1 (en) | 2017-02-09 |
| WO2017021920A1 (en) | 2017-02-09 |
| US10273244B2 (en) | 2019-04-30 |
| US20190194225A1 (en) | 2019-06-27 |
| AU2016303558B2 (en) | 2020-08-06 |
| EP3331886A1 (en) | 2018-06-13 |
| US10584135B2 (en) | 2020-03-10 |
| CA2992820C (en) | 2022-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1250029A1 (zh) | 具有雙環結構的多巴胺d3受體拮抗劑 | |
| HK1231382A1 (zh) | 毒蕈碱受體激動劑 | |
| IL276400A (en) | Dopamine D3 receptor antagonist compounds | |
| IL288907A (en) | A pharmaceutical combination containing a selective s1p1 receptor agonist | |
| GB201702617D0 (en) | Receptor | |
| GB201521722D0 (en) | A dispenser | |
| IL258606B (en) | Dopamine d3 receptor antagonists with a morpholine complex | |
| EP3865472C0 (en) | THROMBOXAN RECEPTOR ANTAGONISTS | |
| GB2524637B (en) | Triggering workflows from a multifunction device | |
| GB2563436B (en) | A device for electrolysis | |
| GB201518125D0 (en) | Dopamine D3 receptor antagonist having a bicyclo moiety | |
| SG11201700014XA (en) | A gasifier | |
| GB201513871D0 (en) | Bicyclo dopamine D3 receptor antagonists | |
| ZA201807767B (en) | Angiotensin-1-receptor antagonists | |
| GB201419433D0 (en) | Dopamine D3 receptor antagonist compounds | |
| GB201419430D0 (en) | Dopamine D3 receptor antagonist compounds | |
| PT3464324T (pt) | Antagonistas de recetores da angiotensina-1 | |
| GB201701887D0 (en) | Receptor | |
| GB201700926D0 (en) | Receptor | |
| GB2544238B (en) | Attachment device for a tubular member | |
| GB201610785D0 (en) | A device for electrolysis | |
| GB201409085D0 (en) | Argon is a mu opioid receptor antagonist | |
| GB201410480D0 (en) | Sulphate metabolite receptors | |
| GB201409094D0 (en) | A dispenser | |
| GB201400207D0 (en) | A soap metering device |